3 completed, 2 unknown, 1 recruiting, 1 terminated. 7 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Unknown 2, Recruiting 1, Terminated 1 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Microvascular Angina: new trials by email Literature Review of Microvascular Angina trials Research Report on Microvascular Angina
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries Amlodipine, Nebivolol, Placebo - Angina Pectoris, Microvascular Angina | Phase 2 / Phase 3 | Recruiting | Stanford University | 150 | 2024-10-10 | 2024-11-27 |
| A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction CLBS16, Placebo - Coronary Microvascular Dysfunction, Coronary Microvascular Disease | Phase 2 | Terminated | Lisata Therapeutics, Inc. | 34 | 2020-10-29 | 2026-05-04 |
| Rhodiola Rosea for Coronary Microvascular Disease Rhodiola Rosea Capsules, Placebo - Coronary Microvascular Disease | Phase 2 / Phase 3 | Unknown | Qilu Hospital of Shandong University | 114 | 2020-01-01 | 2020-01-06 |
| Precision Medicine With Zibotentan in Microvascular Angina Zibotentan, Placebo oral tablet - Microvascular Angina | Phase 2 | Completed | NHS Greater Glasgow and Clyde | 225 | 2019-10-18 | 2023-08-04 |
| Hierarchical Treatment Based on Somatization Symptom Checklist Deanxit, Prozac, coronary artery disease treatment - Syndrome X | Phase 1 / Phase 2 | Unknown | RenJi Hospital | 200 | 2015-12-01 | 2020-03-04 |
| Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA) Ranolazine, Placebo - Microvascular Angina | Phase 2 | Completed | Emory University | 26 | 2014-09-01 | 2019-05-21 |
| The Impact of Cardiac Rehabilitation Participation on Cardiac Syndrome X Phase III group-based cardiac rehabilitation - Microvascular Angina | Phase 2 | Completed | National Heart and Lung Institute | 64 | 2003-01-01 | 2015-04-22 |
Angina Pectoris (3) · Angina Pectoris, Variant (1) · Chest Pain (1)
Cardiovascular Diseases (7) · Heart Diseases (7) · Myocardial Ischemia (7) · Vascular Diseases (7) · Angina Pectoris (4) · Neurologic Manifestations (4) · Pain (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Chest Pain (3) · Angina, Unstable (1)
Amlodipine (1) · Fluoxetine (1) · Nebivolol (1) · Ranolazine (1) · ZD4054 (1) · flupentixol, melitracen drug combination (1)
Emory University (1) · Lisata Therapeutics, Inc. (1) · NHS Greater Glasgow and Clyde (1) · National Heart and Lung Institute (1) · Qilu Hospital of Shandong University (1) · RenJi Hospital (1) · Stanford University (1)
United States (3) · United Kingdom (2) · China (1)
Habib Samady, MD (1) · Jennifer Tremmel, MD (1) · Kristen K Buck, MD (1) · Mao Jialiang, Docter (1) · Peter Collins, MD FRCP (1)
PMID 18188136, PMID 25760881, PMID 33272036, PMID 34066713, PMID 39217504, PMID 41687797